Evidence map›Paper›PMID 19179885›Full record

Trial reportJournal of pediatric gastroenterology and nutrition2009

A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Mark A Underwood, Nita H Salzman, Stephen H Bennett, Melissa Barman, David A Mills, Angela Marcobal, Daniel J Tancredi, Charles L Bevins, Michael P Sherman

Registry-linked trialOpen access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric gastroenterology and nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00282113 (Efficacy of a Prebiotic and Probiotic Combination in Preterm Infants), which is not on this map. Cited by 77 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 14 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00282113 nacompletednot on this map

Efficacy of a Prebiotic and Probiotic Combination in Preterm Infants

TypeinterventionalSponsorUniversity of California, DavisRan2004 to 2007Enrolled90ConditionsPremature Infants, Stool Bacterial Composition, GrowthArmsProBioPlus, Culturelle, Placebo
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 14 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2014
    Pooled it
  10. Pooled it
  11. Prebiotics in infants for prevention of allergy.The Cochrane database of systematic reviews · 2013
    Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mark A UnderwoodDepartment of Pediatrics, University of California, Davis, 95616, USA. munderwood@ucdavis.edu
Nita H Salzman
Stephen H Bennett
Melissa Barman
David A Mills
Angela Marcobal
Daniel J Tancredi
Charles L Bevins
Michael P Sherman
University of California, Davis · USMedical College of Wisconsin · USPediatrics and Genetics · USSouthern Illinois University School of Medicine · USUniversity of California Davis Medical Center · US

Funding

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
Regulation Paneth cell defensins by bacterial infectionR01AI057757 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI SALZMAN, NITA H · 2005 to 2009
$1.4M
NCRR NIH HHS UL1 RR024146NCRR NIH HHS UL1RR024146NIAID NIH HHS R01 AI057757
6 · The paper itself

Abstract

objectiveTo compare the effect of 2 prebiotic/probiotic products on weight gain, stool microbiota, and stool short-chain fatty acid (SCFA) content of premature infants. PATIENTS AND

methodsThis randomized, blinded, placebo-controlled trial included 90 premature infants treated with either a dietary supplement containing 2 lactobacillus species plus fructooligosaccharides (CUL, Culturelle, ConAgra, Omaha, NE), a supplement containing several species of lactobacilli and bifidobacteria plus fructooligosaccharides (PBP, ProBioPlus DDS, UAS Laboratories, Eden Prairie, MN), or placebo (a dilute preparation of Pregestamil formula) twice daily for 28 days or until discharge if earlier. The primary outcome was weight gain. Secondary outcomes were stool bacterial analysis by culture and 16S rDNA quantitative polymerase chain reaction and stool SCFA content measured by high performance liquid chromatography.

resultsBoth prebiotic/probiotic combinations contained more bacterial species than noted on the label. No significant effect on infant growth of either prebiotic/probiotic supplement was observed. By cultures, 64% of infants receiving PBP became colonized with bifidobacteria, compared with 18% of infants receiving CUL and 27% of infants receiving placebo (chi-square, P = 0.064). No differences were noted between groups in colonization rates for lactobacilli, Gram-negative enteric bacteria, or staphylococci. By 16S rDNA polymerase chain reaction analysis, the bifidobacteria content in the stools of the infants receiving PBP was higher than in the infants receiving CUL or placebo (Kruskal-Wallis, P = 0.011). No significant differences in stool SCFA content were detected between groups. No adverse reactions were noted.

conclusionsInfants receiving PBP were more likely to become colonized with bifidobacteria. No significant differences in weight gain or stool SCFA content were detected.

Indexed as

Weight GainAdministration, OralBifidobacteriumChromatography, High Pressure LiquidColony Count, MicrobialFatty Acids, VolatileFecesFemaleGastrointestinal TractGestational AgeHumansInfant, NewbornInfant, PrematureLactobacillusMaleOligosaccharidesFatty Acids, VolatilefructooligosaccharideOligosaccharides

Identifiers

PMID19179885
PMCPMC2743418
OpenAlexW2027338113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.